In this episode, Dr. Slavin speaks with Dr. Tuya Pal about the opportunities and challenges she has seen from the COVID-19 pandemic surrounding clinical cancer care and research.
About Our Guest:
Dr. Tuya Pal, MD is Associate Director for Cancer Health Disparities and Ingram Associate Professor of Cancer Research at Vanderbilt-Ingram Cancer Center. She is a nationally recognized physician-scientist expert in hereditary cancer genetics. https://www.vicc.org/member/tuya-pal